Our Products
Regulatory StatusProduct List
| Product Name | Therapeutic segment | USDMF | CEP | DMF in CTD |
|---|---|---|---|---|
| Albuterol / Salbutanol sulphate | Anti – Asthmatic |  |
|
|
| Aripiprazole | CNS | |
|
|
| Ciprofloxacin Base | Fluoroquinolones | |
|
|
| Ciprofloxacin Hydrochloride | Fluoroquinolones | |
|
|
| Darifenacin HydroBromide | Anti – Spasmodic | Yet to be filed | ||
| Donepezil HCL Form – I and Form – III | CNS | |
|
|
| Enalapril Maleate | Cardiovascular | |
|
|
| Entacapone Form A | CNS | |
|
|
| Enrofloxacin | Fluoroquinolones | Yet to be filed | ||
| Eprosartan Mesylate | Cardiovascular | |
|
|
| Escitalopram Oxalate | CNS | |
|
|
| Ezetimibe | Cardiovascular | |
|
|
| Flecainide Acetate | Cardiovascular | Yet to be filed | ||
| Fluticasone Propionate | Corticosteroids | Yet to be filed | |
|
| Ipratropium Bromide | Anti – Asthmatic | |
|
|
| Itraconazole Powder | Anti – Fungal | |
|
|
| Labetalol Hydrochloride | Cardiovascular | Yet to be filed | |
|
| Levetiracetam | CNS | |
|
|
| Levofloxacin Hemihydrate | Fluoroquinolones | |
|
|
| Linezolid | Anti – Bacterial | Yet to be filed | ||
| Mirtazapine | CNS | |
|
|
| Montelukast Sodium | Anti – Asthmatic | Yet to be filed | ||
| Moxifloxacin Hydrochloride | Fluoroquinolones | |
|
|
| Nateglinide | Anti-Diabetic | Yet to be filed | ||
| Ofloxacin | Fluroquinolones | |
|
|
| Olanzapine Form – I | CNS | |
|
|
| Pirbuterol Acetate | Anti – Asthmatic | Yet to be filed | ||
| Ramipril | Cardiovascular | |
|
|
| Ranitidine Hydrochloride (Form - I) | Anti-Ulcerant | |
|
|
| Ranitidine Hydrochloride (Form - II) | Anti-Ulcerant | |
|
|
| Ropinirole Hydrochloride | CNS | |
|
|
| Rosuvastatin Calcium | Cardiovascular | Yet to be filed | ||
| Salmeterol Xinafoate | Anti – Asthmatic | |
|
|
| Sotalol Hydrochloride | Cardiovascular | |
|
|
| Terbutaline Sulphate | Anti – Asthamatic | Yet to be filed | |
|
| Tiotropium Bromide | Anti – Asthamatic | |
|
|
| Voriconazole | Anti – Fungal | Yet to be filed |
DMFs are available on request.
Products covered by valid patents in any country, are not offered or supplied to those countries.
The patent position in the country concerned should be verified by the customer.